Abstract

Insulin degrading enzyme (IDE) is believed to be the major enzyme that metabolizes insulin and has been implicated in the degradation of a number of other bioactive peptides, including amyloid beta peptide (Aβ), glucagon, amylin, and atrial natriuretic peptide. IDE is activated toward some substrates by both peptides and polyanions/anions, possibly representing an important control mechanism and a potential therapeutic target. A binding site for the polyanion ATP has previously been defined crystallographically, but mutagenesis studies suggest that other polyanion binding modes likely exist on the same extended surface that forms one wall of the substrate-binding chamber. Here we use a computational approach to define three potential ATP binding sites and mutagenesis and kinetic studies to confirm the relevance of these sites. Mutations were made at four positively charged residues (Arg 429, Arg 431, Arg 847, Lys 898) within the polyanion-binding region, converting them to polar or hydrophobic residues. We find that mutations in all three ATP binding sites strongly decrease the degree of activation by ATP and can lower basal activity and cooperativity. Computational analysis suggests conformational changes that result from polyanion binding as well as from mutating residues involved in polyanion binding. These findings indicate the presence of multiple polyanion binding modes and suggest the anion-binding surface plays an important conformational role in controlling IDE activity.

Document Type

Article

Publication Date

7-17-2015

Notes/Citation Information

Published in PLOS One, v. 10, no. 7, article e0133114, p. 1-19.

© 2015 Song et al.

This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

Digital Object Identifier (DOI)

http://dx.doi.org/10.1371/journal.pone.0133114

Funding Information

This work was supported by United States Department of Health and Human Services, National Institutes of Health grants NS38041 (DWR); DA02243, DA016176, and GM110787 (LBH); and AI081982, GM020501, and AI101436 (SL). RP gratefully acknowledges support from the National Science Foundation (CHE1152846). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

journal.pone.0133114.s001.TIF (875 kB)
S1 Fig. RMSD of the IDE<sup>wt</sup> and IDE mutants simulation trajectories versus time.

journal.pone.0133114.s002.TIF (663 kB)
S2 Fig. RMSD of ATP bound at each of three different sites simulation trajectories versus time.

journal.pone.0133114.s003.TIF (1427 kB)
S3 Fig. Superposition snapshots of IDE with ATP bound at Site 1 at 5, 10, 15, 20, 25, and 30 ns time points of the simulations.

journal.pone.0133114.s004.TIF (1314 kB)
S4 Fig. Superposition snapshots of IDE with ATP bound at Site 2 at 5, 10, 15, 20, 25, and 30 ns time points of the simulations.

journal.pone.0133114.s005.TIF (1502 kB)
S5 Fig. Superposition snapshots of IDE with ATP bound at Site 3 at 5, 10, 15, 20, 25, and 30 ns time points of the simulations.

journal.pone.0133114.s006.TIF (7352 kB)
S6 Fig. Secondary structure assignment of IDE<sup>wt</sup> for each residue versus time in the simulation.

journal.pone.0133114.s007.TIF (7271 kB)
S7 Fig. Secondary structure assignment of IDE<sup>wt</sup> with ATP bound at Site 1 for each residue versus time in the simulation.

journal.pone.0133114.s008.TIF (7263 kB)
S8 Fig. Secondary structure assignment of IDE<sup>wt</sup> with ATP bound at Site 2 for each residue versus time in the simulation.

journal.pone.0133114.s009.TIF (7305 kB)
S9 Fig. Secondary structure assignment of IDE<sup>wt</sup> with ATP bound at Site 3 for each residue versus time in the simulation.

journal.pone.0133114.s010.TIF (7251 kB)
S10 Fig. Secondary structure assignment of IDE<sup>R429S</sup> for each residue versus time in the simulation.

journal.pone.0133114.s011.TIF (7280 kB)
S11 Fig. Secondary structure assignment of IDE<sup>R431A</sup> for each residue versus time in the simulation.

journal.pone.0133114.s012.TIF (7223 kB)
S12 Fig. Secondary structure assignment of IDE<sup>R847T</sup> for each residue versus time in the simulation.

journal.pone.0133114.s013.TIF (7357 kB)
S13 Fig. Secondary structure assignment of IDE<sup>R898A</sup> for each residue versus time in the simulation.

journal.pone.0133114.s014.TIF (2062 kB)
S14 Fig. Structural changes accompanying ATP binding at Site 1.

journal.pone.0133114.s015.TIF (2188 kB)
S15 Fig. Structural changes accompanying ATP binding at Site 2.

journal.pone.0133114.s016.TIF (1962 kB)
S16 Fig. Structural changes accompanying ATP binding at Site 3.

journal.pone.0133114.s017.TIF (1761 kB)
S17 Fig. Structural changes in IDE<sup>R431A</sup> versus the wild type enzyme.

journal.pone.0133114.s018.TIF (1303 kB)
S18 Fig. Structural changes in IDE<sup>R847T</sup> versus the wild type enzyme.

journal.pone.0133114.s019.TIF (1075 kB)
S19 Fig. Structural changes in IDE<sup>K898A</sup> versus the wild type enzyme.

journal.pone.0133114.s020.TIF (1076 kB)
S20 Fig. Structural changes in IDE<sup>R429S</sup> versus the wild type enzyme.

Share

COinS